Significant target organs for hypertension and cardiac hypertrophy by angiotensin-converting enzyme inhibitors.

作者: Shinji TAKAI , Denan JIN , Masato SAKAGUCHI , Mizuo MIYAZAKI

DOI: 10.1291/HYPRES.27.213

关键词:

摘要: To clarify the mechanisms by which angiotensin-converting enzyme (ACE) inhibitors lower blood pressure or inhibit cardiac hypertrophy, we analyzed correlations among tissue ACE activities, and hypertrophy. In spontaneously hypertensive rats (SHR), pressure, heart weight activities in plasma various tissues were measured 3, 24 48 h after repeated daily treatment for 2 weeks with trandolapril, perindopril, temocapril enalapril. For all four inhibitors, plasma, aorta kidney significantly reduced 3 last treatment. Although hypotensive effects maintained at h, not suppressed Even enalapril could suppress activity brain, heart. Significant between observed while brain correlated changes pressure. decreases ratio of to body SHR treated trandolapril whereas they The was vascular may be important targets terms ability respectively.

参考文章(23)
Denan Jin, Shinji Takai, Naotaka Shiota, Mizuo Miyazaki, Roles of vascular angiotensin converting enzyme and chymase in two-kidney, one clip hypertensive hamsters. Journal of Hypertension. ,vol. 16, pp. 657- 664 ,(1998) , 10.1097/00004872-199816050-00013
Peter Gohlke, Bernward Schölkens, Rainer Henning, Hansjörg Urbach, Thomas Unger, Inhibition of converting enzyme in brain tissue and cerebrospinal fluid of rats following chronic oral treatment with the converting enzyme inhibitors ramipril and Hoe 288. Journal of Cardiovascular Pharmacology. ,vol. 14, ,(1989) , 10.1097/00005344-198900000-00008
N Shiota, M Miyazaki, H Okunishi, Increase of angiotensin converting enzyme gene expression in the hypertensive aorta. Hypertension. ,vol. 20, pp. 168- 174 ,(1992) , 10.1161/01.HYP.20.2.168
Mizuo Miyazaki, Hideki Okunishi, Tomio Okamura, Noboru Toda, Elevated vascular angiotensin converting enzyme in chronic two-kidney, one clip hypertension in the dog. Journal of Hypertension. ,vol. 5, pp. 155- 160 ,(1987) , 10.1097/00004872-198704000-00005
Masahiro Nagano, Jitsuo Higaki, Hiroshi Mikami, Mitsuaki Nakamaru, Koichi Higashimori, Katsutoshi Katahira, Yoshikatsu Tabuchi, Atsushi Moriguchi, Fumiaki Nakamura, Toshio Ogihara, Converting enzyme inhibitors regressed cardiac hypertrophy and reduced tissue angiotensin II in spontaneously hypertensive rats Journal of Hypertension. ,vol. 9, pp. 595- 599 ,(1991) , 10.1097/00004872-199107000-00003
Tomiichiro Oda, Yasuteru Tijima, Toshio Sada, Hiroshi Nishino, Kiyoshi Oizumi, Hiroyuki Koike, Effects of chronic treatment with a novel angiotensin converting enzyme inhibitor, CS622, and a vasodilator, hydralazine, on atrial natriuretic factor (ANF) in spontaneously hypertensive rats (SHR) Biochemical and Biophysical Research Communications. ,vol. 152, pp. 456- 462 ,(1988) , 10.1016/S0006-291X(88)80735-6
Lina T. Jablonskis, Paul F. Rogers, Yvonne K. Lungershausen, Peter R.C. Howe, Chronic central administration of enalaprilat lowers blood pressure in stroke-prone spontaneously hypertensive rats. Journal of The Autonomic Nervous System. ,vol. 39, pp. 119- 126 ,(1992) , 10.1016/0165-1838(92)90052-I
Tetsutaro Tamura, Suleman Said, Jennifer Harris, Wenyan Lu, A Martin Gerdes, None, Reverse Remodeling of Cardiac Myocyte Hypertrophy in Hypertension and Failure by Targeting of the Renin-Angiotensin System Circulation. ,vol. 102, pp. 253- 259 ,(2000) , 10.1161/01.CIR.102.2.253
H. Okunishi, T. Kawamoto, Y. Kurobe, Y. Oka, K. Ishii, T. Tanaka, M. Miyazaki, PATHOGENETIC ROLE OF VASCULAR ANGIOTENSIN‐CONVERTING ENZYME IN THE SPONTANEOUSLY HYPERTENSIVE RAT Clinical and Experimental Pharmacology and Physiology. ,vol. 18, pp. 649- 659 ,(1991) , 10.1111/J.1440-1681.1991.TB01639.X
A Kinoshita, H Urata, F M Bumpus, A Husain, Measurement of angiotensin I converting enzyme inhibition in the heart. Circulation Research. ,vol. 73, pp. 51- 60 ,(1993) , 10.1161/01.RES.73.1.51